$4.220
+0.020 (+0.48%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
ARTV 相似圖表分析預測
Alphio's ARTV stock price prediction model matches the current Artiva Biotherapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.10 (-0.76%). The 1-week path is $4.04 (-2.38%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
該買進 Artiva Biotherapeutics Inc 股票嗎？
Artiva Biotherapeutics is not a good buy right now due to significant financial losses and recent downgrades by analysts. The current price is $4.19, which is near the downgraded price target of $4 from Jefferies and Wedbush. The RSI is extremely low at 12.93, indicating oversold conditions, but the company's ongoing net losses, which reached $23.5 million in Q1 2026, and the discontinuation of its lead program due to safety concerns, present substantial risks. The main risk is the potential for further declines in share price given the negative sentiment and recent analyst downgrades.
ARTV 股價於 Wednesday 收在 $4.22，此前上漲 +0.48%
Artiva Biotherapeutics Inc (ARTV) last closed at $4.1350002, losing -2.01%. These facts feed the 1-day and 1-week ARTV price prediction above.
預測驅動因素
Artiva Biotherapeutics Inc（ARTV）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
相似圖表形態
近期走勢與 ARTV 最接近的股票，依相似度排序。
ARTV 季節性分析
Historically the probability of a positive November return for ARTV is 18.60%. June offers the highest probability of a positive month at 51.22%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
ARTV 十年價格預測
| 月份 | 最低價 | 平均價 | 最高價 | 潛在報酬率 |
|---|---|---|---|---|
| Nov 2026 | $2.11 | $2.54 | $2.64 | -38.57% |
| Dec 2026 | $2.58 | $2.89 | $3.02 | -30.21% |
2026 年，Artiva Biotherapeutics Inc（ARTV）預計區間為 $2.11 至 $3.02。
Artiva Biotherapeutics Inc 2026 年月度預測
2026 年 Nov，Artiva Biotherapeutics Inc 預計均價 $2.54，最低 $2.11，最高 $2.64。
2026 年 Dec，Artiva Biotherapeutics Inc 預計均價 $2.89，最低 $2.58，最高 $3.02。
相關文章
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。